Balaji, M S, and M Girish. 2022. “A Study of Utility of Delta IgG As a Prognostic Marker in Guillain Barre Syndrome After IV Immunoglobulin Treatment”. International Journal of Health Sciences 6 (S5):4274-87. https://doi.org/10.53730/ijhs.v6nS5.9555.